Final Expense Life Insurance With Hepatitis C
Quick Tip: Complete the Instant Quotes form to receive an instant listing of carrier quotes - free - with no obligation. You can begin your free online research - right now...
You may qualify for Final Expense Life Insurance With Hepatitis C. We also covered this topic here. It is important you know how to qualify for this life insurance benefit available to you. This benefit will pay for 100% of all funeral expenses up to $35,000. This payment is tax free for Virginia residents. You are entitled to receive no-cost information as a resident of Virginia. IMPORTANT – Return this postage paid card within 5 days.
If you are currently undergoing treatment for hepatitis C you may qualify for a final expense life insurance policy or a small affordable burial plan at the standard rate with the following guarantees:
These programs have the following guarantees
1. First Day Coverage. You are fully protected the very first day your coverage goes into effect with no exclusions and no waiting period.
2. Ease of issue. No physical exams.
3. Your premiums will never go up. Lock into a rate at your current age and the cost will never increase regardless of changes to your health and age.
4. Your benefits will never go down. Regardless of changes to your health and age.
5. All programs build cash values.
6. The benefit is paid to your beneficiary tax free on the worst week of their life.
7. Your policy can never be cancelled as long as premium payments are made.
8. This is a protected asset that you will never be forced to liquidate.
Furthermore, if you work with us here at LifePolicyShopper to help you find Final Expense Life Insurance With Hepatitis C, we can put you on a clock and roll you onto a plan at a preferred rate. We know the time requirements among many carriers in the marketplace that approve individuals for first day coverage at a preferred rate that have completed a hepatitis C treatment program after a certain number of months.
There is no reason to go without coverage for your family when you’re undergoing treatment for hepatitis C. And there’s absolutely no reason for you to pay for a guaranteed issue plan that has a two year wait or return of premiums only. If you are not on a first day coverage plan please request a quote and we will enroll you in first day coverage. Let us help you with Final Expense Life Insurance With Hepatitis C.
Viral hepatitis is the infection and subsequent inflammation of the liver caused by any one of several viruses. Most cases of hepatitis are caused by one of five viral agents: hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and hepatitis E virus (HEV). A sixth virus, hepatitis G virus (HGV), has been discovered, but little is known about it. The most common hepatitis viruses are types A, B, and C. Viral hepatitis destroys hepatic cells, causing them to become necrotic. When clients are generally healthy, hepatic cells can regenerate; however, this is less likely in elderly people. Viral hepatitis can be either acute or chronic. The disease is reported to the public health department for proper follow-up because of the possibility of contagion.
There are about 150,000 new cases of hepatitis C every year in the united states. It is transmitted through transfusions from asymptomatic individuals or through contaminated needles. It is spread similarly to hepatitis B, and its incubation period is 2 to 12 weeks. This disease often insidiously damages the liver for up to 20 years before symptoms emerge; an estimated 3.5 million Americans are infected with the chronic form of hepatitis C. Those with the chronic form of the disease can infect others. They are at high risk for cirrhosis, liver failure, and liver cancer.
In many people, there may be no symptoms. When symptoms develop, they may be flulike and include malaise, fatigue, anorexia, myalgia, fever, dark-colored urine, clay colored stools, rashes, hives, abdominal pain or tenderness, pruritus, and jaundice. Nausea, vomiting, headache, photophobia, cough, and coryza (cold) may precede jaundice. An aversion to smoking and certain foods is common.
For the acute form of hepatitis, clients are treated with general supportive measures. Bed rest, adequate diet, and fluid intake are advised. Antiemestis may be ordered. In the recovery phase, the symptoms subside but the liver enlargement and abnormalities are evident. Recovery may take 1 to 4 months, depending on the individual and the type of hepatitis. Short term protection from HAV is available from immune globulin (lgG) that can be given with 2 weeks of exposure. When the hepatitis is chronic, both HBV and HCV infections may respond to interferon. Adefovir dipivoxil and lamivudine are also licensed for treatment for HBV infection. Ribavirin may be effective with HCV infection an is usually given in combination with interferon.
Treatment depends on the cause of the liver failure and the extent of the liver failure but may include: diuretics for fluid overload, lactulose for confusion, blood products or vitamin K for bleeding, and/or antibiotics for infection. A surgical procedure, called transjugular intrahepatic portosystemic shunt (TIPS) or liver transplant may be recommended.
Until recently, there was no cure for chronic hepatitis C. But new antiviral drugs, such as simeprevir (Olysio, sofosbuvir (Sovaldi), sofosbuvir-ledipasvir combination (Harvoni), suggest cure for some may be possible. In some instances, the infection causes liver failure and those individuals may be considered for a liver transplant. Hepatitis A and B vaccines will most likely be recommended to prevent further damage to the liver.
Peginterferon Alfa-2A is used alone or in combination with ribavarin (a medication) to treat chronic (long term) hepatitis C infection (selling of the liver caused by a virus) in people who show signs of liver damage and who have not been treated with interferon alpha (medication similar to peg-interferon alfa-2a) in the past. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2A is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginerferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2A may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2A may not prevent the spread of hepatitis C or hepatitis B to other people.
Peginterferon Alfa-2B is used alone or in combination with ribavarin (a medication) to treat chronic (long term) hepatitis C infection (selling of the liver caused by a virus) in people who show signs of liver damage and who have not been treated with interferon alpha (medication similar to peg-interferon alfa-2B) in the past. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2B is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginerferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2B may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2B may not prevent the spread of hepatitis C or hepatitis B to other people.
Ribavirin is used with an interferon medication such as peginterferon alfa-2A (Pegasys) or peginterferon alpha-2B (PEG-Intron) to treat hepatitis C in people who have not been treated with an interferon before. Ribavirin is in a class of antiviral medications called nucleoside analogues. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if treatment that includes ribavirin and another medication cures hepatitis C infection, prevents live damage that may be caused by hepatitis C, or prevents the spread of hepatitis C to other people.
HARVONI transformed hepatitis C treatment as the first cure that's one pill, once a day. There's no interferon, no complex regimens.HARVONI is a prescription medicine used with or without ribavirin to treat chronic (lasting a long time) hepatitis C genotype 1, 4, 5 or 6 infection. It is not known if HARVONI is safe and effective in children under 18 years of age. HARVONI is a prescription medicine used with or without ribavirin to treat chronic (lasting a long time) hepatitis C genotype 1, 4, 5 or 6 infection. It is not known if HARVONI is safe and effective in children under 18 years of age.
If you are being treated for hepatitis C and you have been declined for a life insurance policy or a burial plan you should contact us at LifePolicyShopper.com. We work with a carrier that offers first day coverage to those being treated for hepatitis C. If you are on a guaranteed issue plan we can most certainly get you first day coverage.
We're so glad you're here - also read our article - Life Insurance For Seniors With Treated Hepatitis C for more information.